Dexcom vs Humana (DXCM vs HUM)

Dexcom (DXCM) vs Humana (HUM) in plain English: P/E, growth, margins, debt and dividend side by side, key differences and which fits each investor profile.

Dexcom (DXCM) and Humana (HUM) compete in healthcare and pharma. Here are Dexcom and Humana side by side with their real figures as of November 4, 2026: what sets them apart, which fits each kind of investor and the most common questions, without telling you whether to buy Dexcom or Humana.

Dexcom vs Humana: the figures

Dexcom and Humana figures from Yahoo Finance, the same source the Fintols analysis uses, retrieved on November 4, 2026; N/A means that Dexcom or Humana figure is not available, and we never estimate it.

3 key differences between Dexcom and Humana

1. Profitability: for every 100 of sales, Dexcom keeps 19.4 as net profit and Humana keeps 0.9.
2. Growth: Humana grew sales +26.2% year on year in its latest quarter, against +11.2% for Dexcom.
3. Volatility: Dexcom stock moves more (beta 1.44) than Humana (beta 0.64); the higher the beta, the more it amplifies market swings.

Dexcom or Humana: which fits your profile

• If you want growth: Humana is growing faster today, so it fits better with investors who put business growth first, usually accepting a higher P/E and a bumpier ride.
• If you want income (dividends): Humana pays the higher dividend relative to its price.
• If you prefer caution: Humana has less debt relative to its profit, which usually gives more room in a bad year.
• If price is what matters most to you: Dexcom trades on the lower P/E; check first whether that is an opportunity or a sign of a business that grows less.

Neither Dexcom nor Humana wins on everything, and owning both is also an option: spreading money across several companies or an index fund reduces what rides on each one.

How Dexcom and Humana make money

Dexcom (DXCM)

Dexcom makes continuous glucose monitors, small sensors worn on the skin that send blood sugar readings to a phone. Most revenue comes from disposable sensors that people with diabetes replace regularly, sold through distributors and pharmacies, and it also offers the over-the-counter Stelo. The United States is its largest market. Full Dexcom analysis.

Humana (HUM)

Humana is a health insurer built around Medicare Advantage, the private plans that replace traditional Medicare for U.S. seniors and its main revenue source. Its Insurance segment covers those plans plus Medicaid and drug coverage, while CenterWell runs primary care clinics, pharmacy services and home health care. Full Humana analysis.

Frequently asked questions: Dexcom vs Humana

Is Dexcom or Humana the better stock?

Choosing between Dexcom and Humana depends on what you are looking for. Humana is growing faster right now, and Dexcom trades on the lower P/E. Fintols does not tell you whether to buy Dexcom or Humana: it shows you the differences so you can decide.

Which pays a higher dividend, Dexcom or Humana?

As of November 4, 2026, Humana yields 0.85% and Dexcom pays none. Also check how much of their profit Dexcom and Humana pay out: if it is more than they earn, it cannot last.

Which is more expensive, Dexcom or Humana?

On P/E, Humana (39.5x) is more expensive than Dexcom (34.8x) as of November 4, 2026. A higher P/E can be justified if earnings grow faster, so compare it with each company's growth in the table.

Can I own both Dexcom and Humana?

Yes. Many people spread their money across several companies, such as Dexcom and Humana, or use index funds so they do not depend on just one. If you are starting out, decide how much you want to invest and for how long before buying Dexcom or Humana.

More comparisons with Dexcom or Humana

• Dexcom vs Moderna
• Dexcom vs Edwards Lifesciences
• Humana vs Moderna
• Edwards Lifesciences vs Humana

More companies like Dexcom and Humana: healthcare and pharma stocks. Educational content about Dexcom and Humana, not investment advice.